A robot used for brain biopsies gave doctors a clear answer in most cases
Original title: Diagnostic yield and safety of Remebot robot-assisted stereotactic biopsy: a 496-case retrospective analysis of intracranial lesions.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This robot is already being used on patients in surgery, but this was a look back at past cases at one hospital, not a planned trial.
The short version
Doctors looked back at 496 brain biopsies done with a robot, and most gave a clear answer with few problems.
What was studied. Doctors at one hospital reviewed the records of 496 patients who had a brain biopsy with a robot system called Remebot between 2023 and 2024. A biopsy takes a tiny piece of tissue so doctors can find out what a growth is. The team checked how often the biopsy gave a clear answer and how often something went wrong.
What they found. The biopsy gave a clear answer in 85.9% of cases, or 426 of 496. The most common finding was high-grade glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary, at 32.7%, followed by blood cancers at 20.4%. Problems around the time of surgery happened in 1.8% of cases, or 9 of 496, and bleeding made up 77.8% of those events. Deeper growths and younger patients were more likely to end up without a clear answer.
What this means, and what it doesn't
What it could mean: A biopsy is often the step that tells you what kind of growth you have. That answer is what your treatment plan is built on. This report suggests a robot can help doctors take that sample and get a usable answer most of the time, with problems being uncommon. If you are facing a brain biopsy, you can ask your team what tools they use and what the risks are for you.
What it doesn't mean: This is not a treatment. A biopsy is a test that helps doctors find out what a growth is. It does not shrink a tumor and it is not a cure. This was also a look back at records from one hospital, not a planned study that compared the robot against another method. So it cannot prove the robot is better than other ways of doing a biopsy. Not every hospital has this system, and your own risk depends on where your growth is and your own health.
Source: PubMed, July 24, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.